BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2840034)

  • 21. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multivariate survival analysis for 423 patients with non-small cell lung cancer].
    Wang W; Rong TH; Zhang L; Jiang WQ; Xu GC; Huang HQ; He YJ; Guan ZZ
    Ai Zheng; 2003 Jun; 22(6):624-8. PubMed ID: 12948414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
    Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in small cell lung cancer: multivariate analysis in the National Cancer Center Hospital (Japan).
    Shinkai T; Sakurai M; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Fukuda M; Yamada K; Kojima A; Sasaki S
    Jpn J Clin Oncol; 1989 Jun; 19(2):135-41. PubMed ID: 2543848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
    Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
    Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor.
    Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M
    Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
    Hermes A; Gatzemeier U; Waschki B; Reck M
    Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
    Paralkar VR; Li T; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification.
    León-Atance P; Moreno-Mata N; González-Aragoneses F; Cañizares-Carretero MÁ; García-Jiménez MD; Genovés-Crespo M; Honguero-Martínez AF; Rombolá CA; Simón-Adiego CM; Peñalver-Pascual R
    Arch Bronconeumol; 2011 Sep; 47(9):441-6. PubMed ID: 21676516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
    Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I
    Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.